Clear Street’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Clear Street’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Hold	21,000	–	–	﹤0.01%	711
2026 Q1	$222K	Hold	21,000	–	–	﹤0.01%	539
2025 Q4	$222K	Sell	21,000 -1,000	-5%	-$10.6K	﹤0.01%	443
2025 Q3	$231K	Hold	22,000	–	–	﹤0.01%	341
2025 Q2	$230K	Buy	22,000 +15,975	+265%	+$166K	﹤0.01%	207
2025 Q1	$61.6K	Sell	6,025 -10,047	-63%	-$101K	﹤0.01%	170
2024 Q4	$160K	Buy	+16,072	New	+$160K	﹤0.01%	105

Other funds holding OACC

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Clear Street's OACC Position: Q2 2026 in Review

Clear Street held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 21,000 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Clear Street first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. The position peaked at $231K in Q3 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

Clear Street held 21,000 shares of Oaktree Acquisition Corp III Life Sciences worth $225K as of Q2 2026.
Clear Street left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #711 holding.
Clear Street first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
Clear Street's Oaktree Acquisition Corp III Life Sciences position peaked at $231K in Q3 2025.
51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.